Literature DB >> 29908914

High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors.

Andrew G Diamos1, Hugh S Mason2.   

Abstract

Recombinant virus-like particles (VLPs) are proven to be safe and effective vaccine candidates. We have previously described a plant-based recombinant protein expression system based on agroinfiltration of a replicating vector derived from the geminivirus bean yellow dwarf virus (BeYDV). The system has been systematically optimized to improve expression and reduce cell death in Nicotiana benthamiana leaves. Using these modifications, we show that VLPs derived from genotype GII.4 norovirus, the leading cause of acute gastroenteritis worldwide, can be produced at >1 mg/g leaf fresh weight (LFW), over three times the highest level ever reported in plant-based systems. We also produced norovirus GI VLPs at 2.3 mg/g LFW. Treatment of VLP-containing crude leaf extracts with acid, detergent, or heat enhanced recovery and allowed selective enrichment of norovirus VLPs. Optimal treatment conditions allowed removal of >90% of endogenous plant proteins without any loss of norovirus VLPs. Selective enrichment of hepatitis B core antigen (HBcAg) VLPs by acid treatment was also demonstrated, with some losses in yield that were partially mitigated in the presence of detergent. Sedimentation analysis confirmed that acid and detergent did not inhibit proper assembly of norovirus VLPs, although heat treatment had a small negative effect. These results demonstrate that milligram quantities of norovirus VLPs can be obtained and highly enriched in a matter of days from a single plant leaf using the BeYDV plant expression system.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29908914     DOI: 10.1016/j.pep.2018.06.011

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  12 in total

Review 1.  Plant-Derived Human Vaccines: Recent Developments.

Authors:  Jennifer Stander; Sandiswa Mbewana; Ann E Meyers
Journal:  BioDrugs       Date:  2022-07-12       Impact factor: 7.744

2.  Production of bacteriophage-encoded endolysin, LysP11, in Nicotiana benthamiana and its activity as a potent antimicrobial agent against Erysipelothrix rhusiopathiae.

Authors:  Md Reyazul Islam; Namil Son; Junho Lee; Dong Wook Lee; Eun-Ju Sohn; Inhwan Hwang
Journal:  Plant Cell Rep       Date:  2019-08-20       Impact factor: 4.570

Review 3.  Future of cancer immunotherapy using plant virus-based nanoparticles.

Authors:  Erum Shoeb; Kathleen Hefferon
Journal:  Future Sci OA       Date:  2019-07-25

4.  High-resolution cryo-EM structures of outbreak strain human norovirus shells reveal size variations.

Authors:  James Jung; Timothy Grant; Dennis R Thomas; Chris W Diehnelt; Nikolaus Grigorieff; Leemor Joshua-Tor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

5.  High Level Production of Monoclonal Antibodies Using an Optimized Plant Expression System.

Authors:  Andrew G Diamos; Joseph G L Hunter; Mary D Pardhe; Sun H Rosenthal; Haiyan Sun; Bonnie C Foster; Michelle P DiPalma; Qiang Chen; Hugh S Mason
Journal:  Front Bioeng Biotechnol       Date:  2020-01-17

6.  N-terminal VP1 Truncations Favor T = 1 Norovirus-Like Particles.

Authors:  Ronja Pogan; Victor U Weiss; Kevin Bond; Jasmin Dülfer; Christoph Krisp; Nicholas Lyktey; Jürgen Müller-Guhl; Samuele Zoratto; Günter Allmaier; Martin F Jarrold; Cesar Muñoz-Fontela; Hartmut Schlüter; Charlotte Uetrecht
Journal:  Vaccines (Basel)       Date:  2020-12-24

7.  Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.

Authors:  Konlavat Siriwattananon; Suwimon Manopwisedjaroen; Balamurugan Shanmugaraj; Kaewta Rattanapisit; Supaporn Phumiamorn; Sompong Sapsutthipas; Sakalin Trisiriwanich; Eakachai Prompetchara; Chutitorn Ketloy; Supranee Buranapraditkun; Wassana Wijagkanalan; Kittipan Tharakhet; Papatsara Kaewpang; Kantinan Leetanasaksakul; Taratorn Kemthong; Nutchanat Suttisan; Suchinda Malaivijitnond; Kiat Ruxrungtham; Arunee Thitithanyanont; Waranyoo Phoolcharoen
Journal:  Front Plant Sci       Date:  2021-05-13       Impact factor: 5.753

8.  Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity.

Authors:  Andrew G Diamos; Mary D Pardhe; Haiyan Sun; Joseph G L Hunter; Tsafrir Mor; Lydia Meador; Jacquelyn Kilbourne; Qiang Chen; Hugh S Mason
Journal:  Vaccine       Date:  2020-03-12       Impact factor: 3.641

Review 9.  Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.

Authors:  Hasnat Tariq; Sannia Batool; Saaim Asif; Mohammad Ali; Bilal Haider Abbasi
Journal:  Front Microbiol       Date:  2022-01-03       Impact factor: 5.640

Review 10.  Application of Plant Viruses in Biotechnology, Medicine, and Human Health.

Authors:  Srividhya Venkataraman; Kathleen Hefferon
Journal:  Viruses       Date:  2021-08-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.